ERBB3 and neoplasm: Interestingly, beyond the enhancement of anti-tumor effects upon the simultaneous inhibition of HER2 + HER3, we also found that this double knockdown counter-acts autocrine cellular adaptation processes that are based on the rapid counter-upregulation of the respective other HER family members after HER2 or HER3 knockdown, respectively.